TY - JOUR
T1 - Radiological features of brain metastases from non-small cell lung cancer harboring EGFR mutation
AU - Takamori, Shinkichi
AU - Toyokawa, Gouji
AU - Shimokawa, Mototsugu
AU - Kinoshita, Fumihiko
AU - Kozuma, Yuka
AU - Matsubara, Taichi
AU - Haratake, Naoki
AU - Akamine, Takaki
AU - Mukae, Nobutaka
AU - Hirai, Fumihiko
AU - Tagawa, Tetsuzo
AU - Oda, Yoshinao
AU - Iwaki, Toru
AU - Iihara, Koji
AU - Honda, Hiroshi
AU - Maehara, Yoshihiko
N1 - Publisher Copyright:
© 2018 International Institute of Anticancer Research. All rights reserved.
PY - 2018/6
Y1 - 2018/6
N2 - Aim: To investigate the radiological features on computed tomography (CT) of brain metastasis (BM) from epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). Patients and Methods: Thirty-four patients with NSCLC with BMs who underwent surgical resection of the BMs at the Department of Neurosurgery, Kyushu University from 2005 to 2016 were enrolled in the study. The EGFR statuses of the 34 BMs were investigated. Radiological features, including the number, size, and location of the tumor, were delineated by CT. Results: Patients with EGFR-mutated BMs had significantly higher frequencies of multiple metastases than those with the non-EGFR-mutated type (p=0.042). BMs harboring mutations in EGFR were more frequently observed in the central area of the brain compared to those without mutations in EGFR (p=0.037). Conclusion: Careful follow-up of patients with EGFR-mutated NSCLC may be necessary given the high frequencies of multiple BMs and their location in the central area of the brain.
AB - Aim: To investigate the radiological features on computed tomography (CT) of brain metastasis (BM) from epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). Patients and Methods: Thirty-four patients with NSCLC with BMs who underwent surgical resection of the BMs at the Department of Neurosurgery, Kyushu University from 2005 to 2016 were enrolled in the study. The EGFR statuses of the 34 BMs were investigated. Radiological features, including the number, size, and location of the tumor, were delineated by CT. Results: Patients with EGFR-mutated BMs had significantly higher frequencies of multiple metastases than those with the non-EGFR-mutated type (p=0.042). BMs harboring mutations in EGFR were more frequently observed in the central area of the brain compared to those without mutations in EGFR (p=0.037). Conclusion: Careful follow-up of patients with EGFR-mutated NSCLC may be necessary given the high frequencies of multiple BMs and their location in the central area of the brain.
UR - http://www.scopus.com/inward/record.url?scp=85048212471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048212471&partnerID=8YFLogxK
U2 - 10.21873/anticanres.12653
DO - 10.21873/anticanres.12653
M3 - Article
C2 - 29848735
AN - SCOPUS:85048212471
SN - 0250-7005
VL - 38
SP - 3731
EP - 3734
JO - Anticancer research
JF - Anticancer research
IS - 6
ER -